Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its ...
YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today ...
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...
The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...
Researchers have found a new way to reactivate fetal hemoglobin without the need for gene-editing therapy, according to a new study.
On the occasion of Janjatiya Gaurav Divas, the Council for Scientific and Industrial Research Institute of Genomic and ...
A Greer couple is hosting a fundraiser to support a costly gene editing procedure for their two children, who suffer from a ...
For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...
Scientists are genetically engineering microbes to withstand industrial conditions for biofuel production. Researchers found that partially suppressing genes in cyanobacteria improved their growth ...
Intellia Therapeutics, Inc. pauses Nex-z gene-editing trial after participant death. Click for my updated look at NTLA stock ...